Natural killer T (NKT) lymphocyte cells are a subset of regulatory lymphocytes with important immunemodulatory effects. Our aim was to evaluate the effect of transplantation of NKT lymphocytes on graft versus host disease (GVHD) in a murine model of semiallogeneic BMT. GVHD was generated by infusion of 2 Â 107 splenocytes from C57BL/6 donor mice into irradiated (C57BL/6 Â Balb/c)F1 recipient mice. Adoptive transfer of increasing numbers of DX5 þ cells was performed. Recipient mice were followed for histological parameters of GVHD-associated liver, bowel, and cutaneous injury. Intrahepatic and intrasplenic lymphocytes were isolated and analyzed by FACS for CD4 þ and CD8 þ subpopulations. It was seen that adoptive transfer of 4.5 Â 106 DX5 þ cells significantly alleviated GVHDrelated hepatic, bowel, and cutaneous injury, and improved survival (85% survival on day 28). In contrast, depletion of DX5 þ cells led to severe GVHD-associated multiorgan injury and 100% mortality. A direct correlation with the number of transplanted DX5 þ cells was noted (maximal effect with transplantation of 4.5 Â 106 DX5 þ cells). Tolerance induction was associated with an increased peripheral CD4/CD8 ratio, intrahepatic trapping of CD8 lymphocytes and a shift towards a Th2-type cytokine profile, manifested by decreased IL-12/IL10, IL-12/IL-4, IFNc/IL-10, and IFNc/IL-4 ratios. Transplantation of DX5 þ cells holds promise as a novel therapeutic measure for GVHD.
Summary:
Natural killer T (NKT) lymphocyte cells are a subset of regulatory lymphocytes with important immunemodulatory effects. Our aim was to evaluate the effect of transplantation of NKT lymphocytes on graft versus host disease (GVHD) in a murine model of semiallogeneic BMT. GVHD was generated by infusion of 2 Â 107 splenocytes from C57BL/6 donor mice into irradiated (C57BL/6 Â Balb/c)F1 recipient mice. Adoptive transfer of increasing numbers of DX5 þ cells was performed. Recipient mice were followed for histological parameters of GVHD-associated liver, bowel, and cutaneous injury. Intrahepatic and intrasplenic lymphocytes were isolated and analyzed by FACS for CD4 þ and CD8 þ subpopulations. It was seen that adoptive transfer of 4.5 Â 106 DX5 þ cells significantly alleviated GVHDrelated hepatic, bowel, and cutaneous injury, and improved survival (85% survival on day 28). In contrast, depletion of DX5 þ cells led to severe GVHD-associated multiorgan injury and 100% mortality. A direct correlation with the number of transplanted DX5 þ cells was noted (maximal effect with transplantation of 4.5 Â 106 DX5 þ cells). Tolerance induction was associated with an increased peripheral CD4/CD8 ratio, intrahepatic trapping of CD8 lymphocytes and a shift towards a Th2-type Keywords: adoptive transfer; graft versus host disease; semiallogeneic bone marrow transplantation; NKT lymphocytes Graft versus host disease (GVHD) is a multiorgan disorder that develops following stem cell transplantation (SCT). 1 The pathogenesis involves recognition of alloreactive antigens, activation of T cells and other immunocompetent effector cells, and tissue destruction. 2 Recently, immune-regulatory T cells, such as CD4 þ CD25 þ T cells and NKT lymphocytes, were shown to have an important role in GVHD. [3] [4] [5] [6] [7] [8] [9] [10] [11] In a murine model of acute GVHD, depletion of CD4 þ CD25 þ cells from the donor T-cell inoculum before transplantation resulted in aggravation of GVHD, while adoptive transfer of donor CD4 þ CD25 þ T cells ameliorated GVHD. 4 In recently published studies, CD4 þ CD25 þ T cells were found to preserve graft-versus-tumor activity, while inhibiting GVHD. 6, 7 Natural killer T (NKT) lymphocytes are a subset of TCRa/b þ CD4 þ or double-negative T lymphocytes that exhibit properties of both innate and adaptive immune cells. 12 These cells were shown to have a regulatory role in various immune-mediated processes, including autoimmune disorders such as experimental allergic encephalomyelitis and type II diabetes. 13, 14 They usually express an invariant T-cell receptor that recognizes glycolipids in the context of the MHC class I-like molecule, CD1d. 15 Upon activation, NKT lymphocytes rapidly secrete either IFNg or IL4, 16 endowing these cells with a capability to mediate both proinflammatory and anti-inflammatory immune responses. [17] [18] [19] [20] [21] [22] Several studies have provided evidence that NKT lymphocytes may be important in GVHD. We have recently shown that induction of oral tolerance towards recipient or donor splenocytes can prevent the development of GVHD in the (C57BL/6 Â Balb/c)F1 semiallogeneic model, suggesting that NKT cells may have a role in this setting. 23, 24 Recently, enrichment of NKT cells in recipient mice by conditioning with fractionated lymphoid irradiation was shown to be protective against GVHD. 8 The relative protection against GVHD conferred by transplantation of marrow T cells in comparison to peripheral T cells was proposed to be secondary to the large population of NKT cells in the marrow. 10 In view of the beneficial effect of NKT lymphocytes in GVHD, our aim was to assess if transplantation of NKT lymphocytes could be a mode of treatment for GVHD in a semiallogeneic murine model of BMT. Our results suggest that transplantation of increasing numbers of NKT lymphocytes effectively ameliorates GVHD.
Materials and methods

Animals
Donor mice were 12-week-old C57BL/6 males, obtained from Jackson Laboratories (Bar Harbor, ME, USA). Recipients were (C57BL/6xBalb/c)F1 female mice. Mice were kept in 12-h light/dark cycles in the Animal Core of the Hadassah-Hebrew University Medical School, and received regular laboratory chow and water ad libitum. Animal experiments were approved by the HebrewUniversity-Hadassah Institutional Committee for the Care and Use of Laboratory Animals. After irradiation and splenocyte transplantation, mice were maintained in laminar flow isolators.
Lymphocyte isolation, separation of NKT cells
Splenocytes were prepared from spleens harvested from donor C57BL mice in the following way: After removal of connective tissue, spleens were placed in a 10 ml dish in cold sterile PBS and crushed through a stainless steel mesh (size 60, Sigma Chemical Co., St Louis, MO, USA). For lymphocyte isolation, 20 ml of histopaque 1077 (Sigma Diagnostics, St Louis, MO, USA) were placed under the cells. Cells at the interface were collected, diluted and washed twice with ice-cold PBS (1250 rpm for 10 min). Approximately 1 Â 10 8 cells/mouse were recovered. To isolate NKT cells, magnetic cell sorting (MACS) with anti-DX5 microbeads (Miltenyi Biotec, Germany) was performed.
It should be noted that anti-DX5 isolates both NKT lymphocytes and natural killer cells; the latter were previously shown to be inert in the context of GVHD. 25 In a preliminary FACS analysis, we have determined that 2.8% of splenocytes are DX5 þ ; 1.6% of splenocytes (57% of DX5 þ cells) are natural killer cells, and 1.2% of splenocytes (43% of DX5 þ cells) are natural killer T cells, which concomitantly express CD3.
Splenocyte transplantation
To induce GVHD, 2 Â 10 7 spleen cells from C57BL/6 donor mice were injected intravenously into (C57BL/ 6xBalb/c)F1 recipient mice. Mice were treated by 60 Co whole-body irradiation (7 Gy) prior to transplantation.
Experimental groups (n ¼ 8 mice/group, Table 1 , and 1.9 Â 10 6 NKT cells) were added, respectively. Recipient mice were followed for survival and histological parameters of GVHD-associated skin, bowel, and liver injury. To determine the mechanism of NKT cell-mediated immune modulation and the role of the liver in tolerance induction, intrahepatic and intrasplenic lymphocytes were isolated and analyzed by FACS for CD4 þ and CD8 þ subpopulations, and serum cytokine levels were determined.
Grading of histologic changes
For evaluation of degree of dermal, hepatic, and intestinal inflammation, tissues were removed and kept in 10% formaldehyde. Five samples from each mouse were embedded in paraffin, sectioned and stained with hematoxylin-eosin by a standard procedure. Slides were examined by two experienced pathologists, who were unaware of the experimental conditions.
Flow cytometry analysis for determination of CD4 þ and CD8 þ T lymphocyte populations
Following lymphocyte isolation, triplicates of 2-5 Â 10 6 cells/500 ml PBS were placed in Falcon 2052 tubes, incubated with 4 ml of 1% BSA for 10 min, and centrifuged at 1400 rpm for 5 min. Cells were resuspended in 10 ml FCS with 1 : 20 FITC-anti mouse CD4 and CD8 antibodies (Pharmingen, USA) for 30 min, washed twice in 1% BSA and kept in 41C until reading. Analytic cell sorting was performed on 1 Â 10 4 cells from each group with a fluorescence-activated cell sorter (FACSTAR plus, Becton Dickinson). Only live cells were counted, and background fluorescence from nonantibody-treated lymphocytes was subtracted from the levels obtained. Gates were set on forward-and side-scatters to exclude dead and red blood cells. Data were analyzed with either the Consort 30 two-color contour plot program (Becton Table 1 Transplanted cells on experiment and control groups 
Measurement of cytokine levels
Blood was centrifuged at 14 000 rpm. Serum IFNg, TNFa, IL-10, IL-4, and IL-12 levels were measured by 'sandwich' ELISA using Genzyme Diagnostics kits (Genzyme Diagnostics, MA, USA).
Statistical analysis
Results were analyzed by the Student's t-test (two tailed).
Results
Effect of adoptive transfer of NKT cells on GVHD-associated mortality
Adoptive transfer of 4.5 Â 10 6 DX5 þ cells (corresponding to 1.9 Â 10 6 NKT cells, group E) significantly improved survival (85% survival on day 28, Figure 1 ). In contrast, depletion of DX5 þ cells (no NKT cells, group B) led to a high rate of mortality (100% mortality on day 14). A direct correlation with the number of transplanted DX5 þ cells was noted (maximal effect with transplantation of 4.5 Â 10 6 DX5 þ cells).
Effect of adoptive transfer of NKT cells on GVHD-associated tissue injury
Adoptive transfer of 4.5 Â 10 6 DX5 þ cells (corresponding to 1.9 Â 10 6 NKT cells, group E) significantly alleviated GVHD-related injury to the skin, small intestine, and liver. In contrast, depletion of DX5 þ (as well as NKT) cells led to severe GVHD-associated multiorgan injury (Figure 2 ).
Alleviation of cutaneous manifestations of GVHD. Skin biopsies were obtained from all mice. In animals from groups A-C, the epidermis showed diffuse vacuolization of the basal cell layer, spongiosis, and dyskeratotic keratinocytes and subepidermal cleft formation, morphological changes characterizing grade II of acute GVHD. In some, subepidermal cleft formation with focal complete loss of the epidermis were observed, compatible with grades III-IV of acute GVHD. Adoptive transfer of NKT cells ameliorated these changes.
Alleviation of intestinal manifestations of GVHD. Small bowel biopsies were obtained from all mice. Significant attenuation of all GVHD-related histologic parameters was observed in correlation to the number of transplanted DX5 þ cells. In controls, apoptotic bodies (single cell necrosis), characteristic of grade I acute GVHD, were seen in many crypts. In some specimen, necrotic debris was present in bowel crypts, compatible with grade II acute GVHD.
Amelioration of GVHD-associated liver disease. In mice transplanted with DX5 þ cells, milder degrees of portal inflammation, lymphocyte infiltration, and disruption of intrahepatic bile ducts were noted with increasing numbers of transplanted cells. In contrast, DX5 þ celldepleted mice developed severe nonsuppurative cholangitis accompanied by endothelialitis; the latter was evident as damage to the venous endothelium, lymphocytic infiltration, and sloughing.
Effect of adoptive transfer of NKT cells on peripheral and intrahepatic CD4 and CD8 lymphocyte subsets Adoptive transfer of increasing numbers of DX5 þ cells significantly increased the peripheral CD4/CD8 ratio (0.34, 0.33, 0.38 in groups C, D, and E, respectively, compared with 0.15 in group B; Figure 3 , Table 2 ). At the same time, the intrahepatic CD4/CD8 ratio was significantly decreased (0.32, 0.14, and 0.03 in groups C, D, and E, respectively, compared with 0.48 in group B; Figure 4 , Table 3 ).
Tolerance induction was associated with intrahepatic trapping of CD8 lymphocytes, manifested by a 2.26 time-fold increase in the peripheral CD4/CD8 ratio, and Induction of peripheral tolerance by transplantation of NKT cells was associated with a significant increase in the peripheral CD4 þ NKT/CD8 þ NKT cell ratio (0.26 vs 0.6 in groups B and E, respectively, Table 2 ) and a significant decrease in the intrahepatic CD4 þ NKT/ CD8 þ NKT cell ratio (0.53 vs 0.05 in groups B and E, respectively, Table 3 ).
Effect of adoptive transfer of NKT cells on serum cytokines
Adoptive transfer of NKT cells induced a Th1 to Th2 cytokine shift. The serum IL-12 level was significantly decreased with increasing numbers of transplanted DX5 þ cells (52 pg/ml vs 735 pg/ml in groups E and B, respectively, Po0.05). Decreased serum IFNg (165 vs 232 pg/ml in groups E and C, respectively) and increased serum IL-4 and IL-10 levels (21.5 vs 12.0 pg/ml for IL-4 and 112 vs 50 pg/ml for IL-10 in group E compared to group B, respectively) were noted in tolerized animals. Although these values did not reach statistical significance, the IL-12/IL-10 ratio was 31.9 time-fold lower in group E compared to group B (0.46 vs 14.7, respectively, Figure 5 ), and the IL-12/IL-4 ratio was 25.4 time-fold lower in group E compared to group B (2.41 vs 61.25, respectively). Changes in the IFNg/IL-10 and IFNg/IL-4 ratios were more modest; the IFNg/IL-10 ratio was 1.82 time-fold lower (1.47 vs 2.68) and the IFNg/ IL-4 ratio 1.45 time-fold lower (7.67 vs 11.16) in group E compared to group B. There was no significant difference in the serum TNFa level between the groups. 
Discussion
Transplantation of DX5 þ cells, some 40% of which are NKT lymphocytes, led to amelioration of GVHD, improving survival and alleviating GVHD-related skin, bowel, and liver injury. This effect was associated with modulation of effector cell subsets, manifested as increased intrahepatic CD8 trapping and an increase in peripheral CD4/CD8 and CD4 þ NKT þ /CD8 þ NKT þ lymphocyte ratios. In addition, a shift in the cytokine profile towards a Th2-type immune response was observed.
Recently, several subsets of immuneregulatory T cells have been characterized, including CD4 þ CD25 þ T lymphocytes and NKT cells. These cells were shown essential for induction and maintenance of self-tolerance and prevention of autoimmunity. 2, [25] [26] [27] As mentioned earlier, CD4 þ CD25 þ T lymphocytes and NKT cells exert a beneficial effect in the setting of GVHD. [3] [4] [5] [6] [7] [8] [9] [10] Depletion of CD4 þ CD25 þ T cells from donor T-cell inoculum resulted in increased GVHD, while addition of IL-2 activated CD4 þ CD25 þ T cells at a 1:1 ratio (post ex vivo expansion) to responder-inducer CD4 þ CD25À T cells resulted in inhibition of the MLR and protection from lethal GVHD. 5 Secretion of IL-10 from CD4 þ CD25 þ T cells was essential for this effect. NKT cells mediate a relative tolerogenicity of marrow transplantation in comparison to transplantation of peripheral T cells. 9 In another study, 7 these cells were shown to confer an IL-4-dependent protective effect against GVHD in TLI-treated animals, in which relative expansion of splenic NKT cells occurs. TLI-treated Balb/c mice were protected from GVHD induced by transplantation of 3 Â 10 6 bone marrow-derived and 0.5 Â 10 6 peripheral blood-derived T cells from donor c57/BL mice. While the total number of transplanted T cells in this study was 3.5 Â 10 6 , most of the T cells were marrow-derived and contained a relatively large number of NKT cells. Thus, the actual number of potentially immunogenic T lymphocytes was approximately 2 Â 10 6 , and the regular T-cell/NKT cell ratio was approximately 1.3:1.
The results of the present study, in which recipients were transplanted with increasing numbers of DX5 þ cells, some 40% of which are NKT lymphocytes, further support an important role for NKT cells in the regulation of GVHD. The number of transplanted DX5 þ cells, although minute in comparison to the total number of transplanted splenocytes, effectively alleviated clinically meaningful GVHD (control mice died by day 14). Lack of specific isolation of NKT lymphocytes by an additional separation with anti-CD3 microbeads, a process in which significant numbers of cells are lost, is a drawback of this study. However, as transplantation of natural killer cells does not improve GVHD, 25 we assume that the beneficial effect observed in this study was mediated by NKT lymphocytes. Interestingly, the aforementioned weakness enabled us to demonstrate that NKT cells exert their beneficial effect despite a relative enrichment of T cells in the DX5-depleted splenocytes (to which DX5 þ cells were added in groups C-E). In view of this, it seems plausible that transplantation of even smaller numbers of NKT cells may suffice in the setting of physiological numbers of T lymphocytes. 28 Strober et al 9 have shown that peripheral blood T cells are at least 30 times more potent than marrow T cells in inducing lethal GVHD in a murine model; the relative tolerogenicity of marrow T cells was attributed to the presence of much higher numbers of NK1.1 þ T cells (approximately 30%) in this population. The fact that transplantation of a relatively small number of NKT lymphocytes in the present study enabled prevention of GVHD induced by a comparably high (2 Â 10 7 ) number of alloreactive peripheral T cells is of special clinical relevance, as allogeneic stem cell transplantations are increasingly being performed from peripheral stem cell grafts. 29, 30 These contain ten-fold more alloreactive T cells (on average) than bone marrow grafts, inducing a more potent GVL effect, at a higher risk of significant GVHD. Transplantation of small numbers of NKT lymphocytes may enable to prevent GVHD without losing the graft versus tumor effect.
The high regular T-cell/NKT cell ratio employed in this study (10:1), the absence of requirement for donor preconditioning (ie TLI), IL-2 stimulation, or ex vivo expansion of NKT cells distinguishes our findings from previously published data. It is worthwhile to note that in the present study, recipient mice were transplanted with 1.6 Â 10 6 NKT lymphocytes, a number that far exceeds the T-cell threshold for GVHD induction. 30 The fact that despite this high inoculum of CD3 þ cells, GVHD did not occur may indicate the inertness of this subset cells.
Activation of CD8 þ T cells in the periphery is often accompanied by lymphocyte trafficking to the liver, where T-cell trapping and activation-induced cell death occur. 31 Active trapping and Fas-mediated apoptosis of CD8 þ T cells underlie liver-induced tolerance in a number of models (ie diabetes). 32 In line with previous studies, in this study we have found a correlation between induction of tolerance and an increased CD8 þ T lymphocyte number in the liver. The mechanism by which NKT lymphocytes may contribute to increased CD8 þ T lymphocyte trapping is not known. In a recently published study, 33 expanded CD8 þ NKT lymphocytes were shown to be relatively inert cells with important antitumor activity. Although it is possible that a decrease in the number of peripheral CD8 þ NKT cells, as observed in this study, might hamper antitumor immunity, this scenario seems unlikely in view of the naturally small number of peripheral CD8 þ NKT lymphocytes.
Transplantation of increasing numbers of peripheral NKT cells in the present study induces a Th2 shift in the cytokine paradigm, manifested by a significant decrease in serum IL-12/IL10, IL12/IL4, IFNg/IL10, and IFNg/IL4 ratios in tolerized animals. Upon activation, NKT cells can rapidly secrete both IFNg and IL4; thus, these cells can generate either Th1 or Th2-type immune responses, and have an important effect on the balance between pro-and anti-inflammatory immune processes. Although IFNg may have a certain role in alleviation of GVHD, 10 our findings are in line with previous studies that have Adoptive 
suggested the centrality of Th2-type responses in this setting. 5, [8] [9] [10] 23 In summary, transplantation of relatively small numbers of NKT lymphocytes improves survival and alleviates clinical and histological GVHD in a semiallogeneic murine model. This effect was observed despite the presence of supraphysiological numbers of T lymphocytes in the inoculum. Alleviation of GVHD was accompanied by a change in the composition and distribution of lymphocyte subsets, which may have led to an altered effector/ suppressor balance. Additionally, in line with previous studies that have shown a role for Th2-type responses in alleviation of GVHD, a shift towards a Th2-type cytokine profile was observed. Finally, the liver may play an important role in prevention of GVHD by trapping of subsets of effector cells that promote injury. Alleviation of GVHD can be achieved by transplantation of resting peripheral blood-derived NKT cells at a low NKT/T cell ratio, without a need for prestimulation or ex vivo expansion maneuvers, facilitating the clinical applicability of this strategy. The fact that transplantation of allogeneic NKT cells does not in itself induce GVHD may enable to employ NKT lymphocytes as a form of cell therapy for various immune-mediated disorders.
